Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 63323-506

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 63323-506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dex16 0001 01

Dex16 0001 01
Chemical compound with a molecular weight of 516.41 g/mol, denoted as CH,OPO(ONa). This compound may be used in various applications.*
FDA Label Image

Dex16 0001 02

FDA Label Image

Dex16 0001 03

FDA Label Image

Dex16 0001 04

Dex16 0001 04
This text provides information about Dexamethasone Sodium Phosphate Injection, USP in 10 mg per mL single-dose vials for intramuscular or intravenous use. The product is preservative-free and each vial contains Dexamethasone sodium phosphate, USP, sodium citrate, and water for injection. Storage conditions and dosage instructions are also included, along with details on the manufacturer, Resenius Kabi, located in Lake Zurich, IL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.